Yu W - Search Results

1

Immunosenescence: a key player in cancer development.

Lian J, Yue Y, Yu W, Zhang Y. Lian J, et al. Among authors: yu w. J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z. J Hematol Oncol. 2020. PMID: 33168037 Free PMC article. Review.

2

Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.

Wang D, Yuan W, Wang Y, Wu Q, Yang L, Li F, Chen X, Zhang Z, Yu W, Maimela NR, Cao L, Wang D, Wang J, Sun Z, Liu J, Zhang Y. Wang D, et al. Among authors: yu w. J Transl Med. 2019 Aug 6;17(1):253. doi: 10.1186/s12967-019-2008-y. J Transl Med. 2019. PMID: 31387598 Free PMC article.

3

Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.

Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, Liu S, Li A, He Z, Liu J, Sun Z, Yuan W, Zhang Y. Wang D, et al. Among authors: yu w. J Immunother Cancer. 2019 Aug 8;7(1):215. doi: 10.1186/s40425-019-0701-2. J Immunother Cancer. 2019. PMID: 31395078 Free PMC article.

4

Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors.

Wang D, Yang L, Yu W, Zhang Y. Wang D, et al. Among authors: yu w. Expert Opin Investig Drugs. 2019 Oct;28(10):903-916. doi: 10.1080/13543784.2019.1672655. Epub 2019 Oct 4. Expert Opin Investig Drugs. 2019. PMID: 31560229 Review.

5

Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target.

Yu W, Yang L, Li T, Zhang Y. Yu W, et al. Front Oncol. 2019 Oct 4;9:989. doi: 10.3389/fonc.2019.00989. eCollection 2019. Front Oncol. 2019. PMID: 31637214 Free PMC article. Review.

6

Th17 cells inhibit CD8⁺ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients.

Wang D, Yu W, Lian J, Wu Q, Liu S, Yang L, Li F, Huang L, Chen X, Zhang Z, Li A, Liu J, Sun Z, Wang J, Yuan W, Zhang Y. Wang D, et al. Among authors: yu w. J Hematol Oncol. 2020 Jun 5;13(1):68. doi: 10.1186/s13045-020-00897-z. J Hematol Oncol. 2020. PMID: 32503584 Free PMC article.

7

DEFB4A is a potential prognostic biomarker for colorectal cancer.

Wu Q, Wang D, Zhang Z, Wang Y, Yu W, Sun K, Maimela NR, Sun Z, Liu J, Yuan W, Zhang Y. Wu Q, et al. Among authors: yu w. Oncol Lett. 2020 Oct;20(4):114. doi: 10.3892/ol.2020.11975. Epub 2020 Aug 12. Oncol Lett. 2020. PMID: 32863927 Free PMC article.

8

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer.

Yang L, Li A, Liu F, Zhao Q, Ji S, Zhu W, Yu W, Zhang R, Liu Y, Li W, Zhang Y. Yang L, et al. Among authors: yu w. Front Cell Dev Biol. 2021 Mar 11;9:596484. doi: 10.3389/fcell.2021.596484. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33777927 Free PMC article.

9

Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.

Zhao Q, Huang L, Qin G, Qiao Y, Ren F, Shen C, Wang S, Liu S, Lian J, Wang D, Yu W, Zhang Y. Zhao Q, et al. Among authors: yu w. Cancer Lett. 2021 Oct 10;518:35-48. doi: 10.1016/j.canlet.2021.06.009. Epub 2021 Jun 15. Cancer Lett. 2021. PMID: 34139285

10

PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.

Shen C, Liu C, Zhang Z, Ping Y, Shao J, Tian Y, Yu W, Qin G, Liu S, Wang L, Zhang Y. Shen C, et al. Among authors: yu w. Front Immunol. 2021 Jun 14;12:680055. doi: 10.3389/fimmu.2021.680055. eCollection 2021. Front Immunol. 2021. PMID: 34194433 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,454 results

Search Page